Letermovir Prophylaxis Is Effective for Cytomegalovirus Reactivation after Allogeneic Hematopoietic Cell Transplantation: Single Center Real-World Data

被引：0
|
作者：
Derigs, Patrick [1 ]
Schubert, Maria-Luisa [1 ]
Schnitzler, Paul [2 ]
Mueller-Tidow, Carsten [1 ]
Luft, Thomas [1 ]
Dreger, Peter [1 ]
Schmitt, Michael [1 ]
机构：
[1] Univ Heidelberg Hosp, Dept Internal Med Hematol Oncol Rheumatol 5, Heidelberg, Germany
[2] Heidelberg Univ Hosp, Dept Virol, Heidelberg, Germany
来源：
BLOOD | 2019年 / 134卷
关键词：
D O I：
10.1182/blood-2019-125675
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
5650
引用
收藏
页数：3
相关论文
共 50 条
  • [31] Letermovir Prophylaxis for Cytomegalovirus in Hematopoietic-Cell Transplantation
    Marty, F. M.
    Ljungman, P.
    Chemaly, R. F.
    Maertens, J.
    Dadwal, S. S.
    Duarte, R. F.
    Haider, S.
    Ullmann, A. J.
    Katayama, Y.
    Brown, J.
    Mullane, K. M.
    Boeckh, M.
    Blumberg, E. A.
    Einsele, H.
    Snydman, D. R.
    Kanda, Y.
    DiNubile, M. J.
    Teal, V. L.
    Wan, H.
    Murata, Y.
    Kartsonis, N. A.
    Leavitt, R. Y.
    Badshah, C.
    NEW ENGLAND JOURNAL OF MEDICINE, 2017, 377 (25): : 2433 - 2444
  • [32] Letermovir for Cytomegalovirus Prophylaxis in Hematopoietic-Cell Transplantation
    Chemaly, Roy F.
    Ullmann, Andrew J.
    Stoelben, Susanne
    Richard, Marie Paule
    Bornhaeuser, Martin
    Groth, Christoph
    Einsele, Hermann
    Silverman, Margarida
    Mullane, Kathleen M.
    Brown, Janice
    Nowak, Horst
    Koelling, Katrin
    Stobernack, Hans P.
    Lischka, Peter
    Zimmermann, Holger
    Ruebsamen-Schaeff, Helga
    Champlin, Richard E.
    Ehninger, Gerhard
    NEW ENGLAND JOURNAL OF MEDICINE, 2014, 370 (19): : 1781 - 1789
  • [33] Letermovir for prophylaxis of cytomegalovirus in allogeneic hematopoietic stem cell recipients
    Cho, J. C.
    Le, A. D.
    Locke, S. C.
    DRUGS OF TODAY, 2018, 54 (06) : 361 - 368
  • [34] Letermovir prophylaxis for cytomegalovirus in pediatric patients undergoing allogeneic hematopoietic stem cell transplantation
    Wang, Qingwei
    Liu, Minyuan
    Zhang, Senlin
    Gao, Li
    Chu, Xinran
    Li, Bohan
    Cheng, Shengqin
    Tian, Yuanyuan
    Zhang, Yongping
    Hu, Yixin
    Li, Jie
    Lu, Jun
    Xiao, Peifang
    Liu, Hu
    Hu, Shaoyan
    BONE MARROW TRANSPLANTATION, 2025, : 422 - 424
  • [35] Cytomegalovirus Infection after Allogeneic Hematopoietic Cell Transplantation under 100-Day Letermovir Prophylaxis: A Real-World 1-Year Follow-Up Study
    Nho, Dukhee
    Lee, Raeseok
    Cho, Sung-Yeon
    Lee, Dong-Gun
    Kim, Eun-Jin
    Park, Silvia
    Lee, Sung-Eun
    Cho, Byung-Sik
    Kim, Yoo-Jin
    Lee, Seok
    Kim, Hee-Je
    VIRUSES-BASEL, 2023, 15 (09):
  • [36] Real-Life Data on the Efficacy and Safety of Letermovir for Primary Prophylaxis of Cytomegalovirus in Allogeneic Hematopoietic Stem Cell Recipients: A Single-Center Analysis
    Wlodarczyk, Martyna
    Wieczorkiewicz-Kabut, Agata
    Bialas, Krzysztof
    Koclega, Anna
    Noster, Izabela
    Zielinska, Patrycja
    Helbig, Grzegorz
    TURKISH JOURNAL OF HEMATOLOGY, 2024, 41 (01) : 9 - 15
  • [37] Letermovir for primary and secondary cytomegalovirus prevention in allogeneic hematopoietic cell transplant recipients: Real-world experience
    Lin, Andrew
    Maloy, Molly
    Su, Yiqi
    Bhatt, Valkal
    DeRespiris, Lauren
    Griffin, Meagan
    Lau, Carmen
    Proli, Anthony
    Barker, Juliet
    Shaffer, Brian
    Giralt, Sergio A.
    Jakubowski, Ann A.
    Papadopoulos, Esperanza B.
    Papanicolaou, Genovefa A.
    Seo, Susan K.
    Perales, Miguel-Angel
    TRANSPLANT INFECTIOUS DISEASE, 2019, 21 (06)
  • [38] Clinical Efficacy of Letermovir Prophylaxis for CMV Infection after Allogeneic Hematopoietic Stem Cell Transplantation: A Single Center Experience
    Satake, Atsushi
    Ichikawa, Jun
    Saito, Ryo
    Konishi, Akiko
    Hotta, Masaaki
    Nakanishi, Takahisa
    Nakaya, Aya
    Fujita, Shinya
    Ito, Tomoki
    Ishii, Kazuyoshi
    Nomura, Shosaku
    BONE MARROW TRANSPLANTATION, 2020, 55 (SUPPL 1) : 479 - 480
  • [39] Clinical "Real-World" Experience with Letermovir for Prevention of Cytomegalovirus Infection in Allogeneic Hematopoietic Cell Transplant Recipients
    Anderson, Anthony D.
    Raja, Mohammed
    Morris, Michele I.
    Komanduri, Krishna V.
    Camargo, Jose F.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2020, 26 (03) : S317 - S318
  • [40] Clinical "real-world" experience with letermovir for prevention of cytomegalovirus infection in allogeneic hematopoietic cell transplant recipients
    Anderson, Anthony
    Raja, Mohammed
    Vazquez, Neisy
    Morris, Michele
    Komanduri, Krishna
    Camargo, Jose
    CLINICAL TRANSPLANTATION, 2020, 34 (07)
12345